Building an eTMF Business
Case at ZS Pharma
Brent Sorrells, senior director of clinical operations at ZS Pharma, explains the decision to adopt Veeva Veeva eTMF, the system’s advantages during acquisition activity, and how his team built a business case for its eventual parent company, AstraZeneca, to also adopt Veeva eTMF.
